Literature DB >> 1952571

Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571.

J B Rasmussen1, D J Margolskee, L O Eriksson, V C Williams, K E Andersson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1952571     DOI： 10.1111/j.1749-6632.1991.tb38010.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Antileukotrienes and laboratory models of asthma.

Authors:  S C Lazarus
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.

Authors:  N C Barnes; J C Pujet
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

Review 3.  Leukotriene receptor antagonists: clinical effects.

Authors:  N Barnes
Journal:  J R Soc Med       Date:  1997-04       Impact factor: 5.344

Review 4.  Leukotriene synthesis inhibitors versus antagonists: the pros and cons.

Authors:  John W Steinke; Jeffrey A Culp
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

5.  Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.

Authors:  M Depré; D J Margolskee; J Y Hsieh; A Van Hecken; A Buntinx; I De Lepeleire; J D Rogers; P J De Schepper
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.